Blueshift Asset Management’s Globus Medical GMED Stock Holding History

Blueshift Asset Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Buy	+3,321	New	+$282K	0.06%	415
2025 Q3	–	Sell	-8,740	Closed	-$516K	–	514
2025 Q2	$516K	Buy	+8,740	New	+$565K	0.16%	179
2024 Q2	–	Sell	-6,711	Closed	-$360K	–	367
2024 Q1	$360K	Buy	+6,711	New	+$361K	0.19%	171
2022 Q2	–	Sell	-3,713	Closed	-$274K	–	801
2022 Q1	$274K	Buy	+3,713	New	+$258K	0.03%	643
2019 Q1	–	Sell	-17,715	Closed	-$767K	–	801
2018 Q4	$767K	Buy	+17,715	New	+$884K	0.14%	230

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Blueshift Asset Management's GMED Position: Q2 2026 in Review

Blueshift Asset Management opened a new position in Globus Medical (GMED) in Q2 2026: 3,321 shares worth $262K. The stake represents 0.06% of the portfolio and ranks #415 among its holdings. This is a return to the name: Blueshift Asset Management previously reported a position in GMED as recently as Q2 2025.

Blueshift Asset Management first reported a position in GMED in Q4 2018 and has held it in 5 quarters since. The position peaked at $767K in Q4 2018. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Blueshift Asset Management held 3,321 shares of Globus Medical worth $262K as of Q2 2026.
Globus Medical was a new Blueshift Asset Management position in Q2 2026.
Globus Medical made up 0.06% of Blueshift Asset Management's portfolio in Q2 2026, its #415 holding.
Blueshift Asset Management first reported a position in Globus Medical in Q4 2018 and has held it in 5 quarters since.
Blueshift Asset Management's Globus Medical position peaked at $767K in Q4 2018.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.